Active 0 6 0 6 O
or 7 9 7 9 O
recent 10 16 10 16 O
( 17 18 17 18 O
within 18 24 18 24 O
prior 25 30 25 30 B-upper_bound
3 31 32 31 32 I-upper_bound
months 33 39 33 39 I-upper_bound
) 39 40 39 40 O
thrombus 41 49 41 49 B-chronic_disease
, 49 50 49 50 O
irrespective 51 63 51 63 O
of 64 66 64 66 O
anticoagulation 67 82 67 82 B-clinical_variable
status 83 89 83 89 I-clinical_variable

Cardiac 0 7 90 97 O
: 7 8 97 98 O
Left 9 13 99 103 B-clinical_variable
ventricular 14 25 104 115 I-clinical_variable
ejection 26 34 116 124 I-clinical_variable
fraction 35 43 125 133 I-clinical_variable
( 44 45 134 135 I-clinical_variable
LVEF 45 49 135 139 I-clinical_variable
) 49 50 139 140 I-clinical_variable
≥ 51 52 141 142 O
35 53 55 143 145 B-lower_bound
% 55 56 145 146 I-lower_bound

Current 0 7 147 154 O
thromboembolic 8 22 155 169 B-chronic_disease
disease 23 30 170 177 I-chronic_disease
requiring 31 40 178 187 O
full 41 45 188 192 O
- 45 46 192 193 O
dose 46 50 193 197 O
anticoagulation 51 66 198 213 B-treatment
- 67 68 214 215 O
patients 69 77 216 224 O
receiving 78 87 225 234 O
pharmacologic 88 101 235 248 B-treatment
prophylaxis 102 113 249 260 I-treatment
for 114 117 261 264 O
thromboembolic 118 132 265 279 O
disease 133 140 280 287 O
will 141 145 288 292 O
be 146 148 293 295 O
eligible 149 157 296 304 O

Diagnosis 0 9 305 314 O
of 10 12 315 317 O
a 13 14 318 319 O
hormone 15 22 320 327 B-cancer
responsive 23 33 328 338 I-cancer
malignancy 34 44 339 349 I-cancer

Failure 0 7 350 357 O
to 8 10 358 360 O
improve 11 18 361 368 O
to 19 21 369 371 O
at 22 24 372 374 O
least 25 30 375 380 O
grade 31 36 381 386 B-lower_bound
II 37 39 387 389 I-lower_bound
acute 40 45 390 395 B-clinical_variable
GVHD 46 50 396 400 I-clinical_variable
after 51 56 401 406 B-upper_bound
14 57 59 407 409 I-upper_bound
days 60 64 410 414 I-upper_bound
of 65 67 415 417 O
systemic 68 76 418 426 B-treatment
corticosteroids 77 92 427 442 I-treatment
, 92 93 442 443 O
with 94 98 444 448 O
initial 99 106 449 456 O
doses 107 112 457 462 O
of 113 115 463 465 O
at 116 118 466 468 O
least 119 124 469 474 O
2 125 126 475 476 B-lower_bound
mg 127 129 477 479 I-lower_bound
/ 129 130 479 480 I-lower_bound
kg 130 132 480 482 I-lower_bound
prednisone 133 143 483 493 B-treatment
or 144 146 494 496 O
equivalent 147 157 497 507 O

Flare 0 5 508 513 O
of 6 8 514 516 O
acute 9 14 517 522 O
GVHD 15 19 523 527 B-chronic_disease
of 20 22 528 530 O
at 23 25 531 533 O
least 26 31 534 539 O
grade 32 37 540 545 B-lower_bound
II 38 40 546 548 I-lower_bound
/ 40 41 548 549 O
IV 41 43 549 551 B-upper_bound
severity 44 52 552 560 O
despite 53 60 561 568 O
tapering 61 69 569 577 O
dose 70 74 578 582 O
of 75 77 583 585 O
steroids 78 86 586 594 O
being 87 92 595 600 O
> 93 94 601 602 O
0.5 95 98 603 606 B-lower_bound
mg 99 101 607 609 I-lower_bound
/ 101 102 609 610 I-lower_bound
kg 102 104 610 612 I-lower_bound
/ 104 105 612 613 I-lower_bound
day 105 108 613 616 I-lower_bound

High 0 4 617 621 O
- 4 5 621 622 O
Risk 5 9 622 626 O
aGVHD 10 15 627 632 B-chronic_disease
( 16 17 633 634 O
ARM 17 20 634 637 O
1 21 22 638 639 O
): 22 24 639 641 O
Pediatric 25 34 642 651 O
or 35 37 652 654 O
adult 38 43 655 660 O
( 44 45 661 662 O
ages 45 49 662 666 B-age
12 50 52 667 669 B-lower_bound
- 52 53 669 670 O
76 53 55 670 672 B-upper_bound
years 56 61 673 678 I-upper_bound
) 61 62 678 679 O
HCT 63 66 680 683 B-treatment
recipients 67 77 684 694 O
with 78 82 695 699 O
high 83 87 700 704 O
- 87 88 704 705 O
risk 88 92 705 709 O
acute 93 98 710 715 O
GVHD 99 103 716 720 O
, 103 104 720 721 O
as 105 107 722 724 O
determined 108 118 725 735 O
by 119 121 736 738 O
the 122 125 739 742 O
refined 126 133 743 750 O
MN 134 136 751 753 O
acute 137 142 754 759 O
GVHD 143 147 760 764 O
risk 148 152 765 769 O
score 153 158 770 775 O
: 158 159 775 776 O
http://z.umn.edu/MNAcuteGVHDRiskScore 160 197 777 814 O
OR 198 200 815 817 O
high 201 205 818 822 O
risk 206 210 823 827 O
on 211 213 828 830 O
the 214 217 831 834 O
basis 218 223 835 840 O
of 224 226 841 843 O
blood 227 232 844 849 O
biomarkers 233 243 850 860 O
( 244 245 861 862 O
Ann 245 248 862 865 O
Arbor 249 254 866 871 O
Score 255 260 872 877 O
3 261 262 878 879 O
or 263 265 880 882 O
amphiregulin 266 278 883 895 B-clinical_variable
≥ 279 280 896 897 O
33 281 283 898 900 B-lower_bound
pg 284 286 901 903 I-lower_bound
/ 286 287 903 904 I-lower_bound
ml 287 289 904 906 I-lower_bound
) 289 290 906 907 O

No 0 2 908 910 O
response 3 11 911 919 O
of 12 14 920 922 O
acute 15 20 923 928 O
GVHD 21 25 929 933 B-chronic_disease
after 26 31 934 939 O
at 32 34 940 942 O
least 35 40 943 948 O
4 41 42 949 950 B-lower_bound
days 43 47 951 955 I-lower_bound
of 48 50 956 958 O
systemic 51 59 959 967 O
corticosteroids 60 75 968 983 B-treatment
of 76 78 984 986 O
at 79 81 987 989 O
least 82 87 990 995 O
2 88 89 996 997 B-lower_bound
mg 90 92 998 1000 I-lower_bound
/ 92 93 1000 1001 I-lower_bound
kg 93 95 1001 1003 I-lower_bound
prednisone 96 106 1004 1014 B-treatment
or 107 109 1015 1017 O
equivalent 110 120 1018 1028 O

Pediatric 0 9 1029 1038 O
or 10 12 1039 1041 O
adult 13 18 1042 1047 O
( 19 20 1048 1049 O
ages 20 24 1049 1053 B-age
0 25 26 1054 1055 B-lower_bound
- 26 27 1055 1056 O
76 27 29 1056 1058 B-upper_bound
years 30 35 1059 1064 I-upper_bound
) 35 36 1064 1065 O
HCT 37 40 1066 1069 B-clinical_variable
recipients 41 51 1070 1080 O

Pediatric 0 9 1081 1090 O
or 10 12 1091 1093 O
adult 13 18 1094 1099 O
( 19 20 1100 1101 O
ages 20 24 1101 1105 B-age
12 25 27 1106 1108 B-lower_bound
- 27 28 1108 1109 O
76 28 30 1109 1111 B-upper_bound
years 31 36 1112 1117 I-upper_bound
) 36 37 1117 1118 O
HCT 38 41 1119 1122 B-treatment
recipient 42 51 1123 1132 O
with 52 56 1133 1137 O
grade 57 62 1138 1143 B-lower_bound
II 63 65 1144 1146 I-lower_bound
- 65 66 1146 1147 O
IV 66 68 1147 1149 B-upper_bound
steroid 69 76 1150 1157 B-chronic_disease
refractory 77 87 1158 1168 I-chronic_disease
or 88 90 1169 1171 O
steroid 91 98 1172 1179 B-chronic_disease
- 98 99 1179 1180 I-chronic_disease
dependent 99 108 1180 1189 I-chronic_disease
acute 109 114 1190 1195 I-chronic_disease
GVHD 115 119 1196 1200 I-chronic_disease
, 119 120 1200 1201 O
defined 121 128 1202 1209 O
as 129 131 1210 1212 O
any 132 135 1213 1216 O
one 136 139 1217 1220 O
of 140 142 1221 1223 O
the 143 146 1224 1227 O
following 147 156 1228 1237 O

Pregnancy 0 9 1238 1247 B-pregnancy
as 10 12 1248 1250 O
assessed 13 21 1251 1259 O
on 22 24 1260 1262 O
baseline 25 33 1263 1271 O
blood 34 39 1272 1277 O
hCG 40 43 1278 1281 O
level 44 49 1282 1287 O

Progression 0 11 1288 1299 O
of 12 14 1300 1302 O
acute 15 20 1303 1308 B-chronic_disease
GVHD 21 25 1309 1313 I-chronic_disease
within 26 32 1314 1320 O
3 33 34 1321 1322 B-upper_bound
days 35 39 1323 1327 I-upper_bound
of 40 42 1328 1330 O
systemic 43 51 1331 1339 B-treatment
corticosteroids 52 67 1340 1355 I-treatment
of 68 70 1356 1358 O
at 71 73 1359 1361 O
least 74 79 1362 1367 O
2 80 81 1368 1369 B-lower_bound
mg 82 84 1370 1372 I-lower_bound
/ 84 85 1372 1373 I-lower_bound
kg 85 87 1373 1375 I-lower_bound
prednisone 88 98 1376 1386 B-treatment
or 99 101 1387 1389 O
equivalent 102 112 1390 1400 O

Progressive 0 11 1401 1412 O
malignancy 12 22 1413 1423 B-cancer

Renal 0 5 1424 1429 O
: 5 6 1429 1430 O
1.73m2Serum 7 18 1431 1442 O
creatinine 19 29 1443 1453 I-clinical_variable
≤2.5x 30 35 1454 1459 O
upper 36 41 1460 1465 I-upper_bound
limit 42 47 1466 1471 I-upper_bound
of 48 50 1472 1474 I-upper_bound
normal 51 57 1475 1481 I-upper_bound
( 58 59 1482 1483 I-upper_bound
ULN 59 62 1483 1486 I-upper_bound
) 62 63 1486 1487 I-upper_bound

Steroid 0 7 1488 1495 B-treatment
- 7 8 1495 1496 O
Refractory 8 18 1496 1506 O
aGVHD 19 24 1507 1512 B-chronic_disease
( 25 26 1513 1514 O
ARM 26 29 1514 1517 O

Suspected 0 9 1518 1527 O
high 10 14 1528 1532 O
risk 15 19 1533 1537 O
GVHD 20 24 1538 1542 B-chronic_disease

Uncontrolled 0 12 1543 1555 B-chronic_disease
infection 13 22 1556 1565 I-chronic_disease
at 23 25 1566 1568 O
initiation 26 36 1569 1579 O
of 37 39 1580 1582 O
protocol 40 48 1583 1591 O
treatment 49 58 1592 1601 B-treatment

Unwilling 0 9 1602 1611 O
or 10 12 1612 1614 O
unable 13 19 1615 1621 O
to 20 22 1622 1624 O
stop 23 27 1625 1629 O
supplemental 28 40 1630 1642 O
sex 41 44 1643 1646 B-treatment
hormone 45 52 1647 1654 I-treatment
therapy 53 60 1655 1662 I-treatment
( 61 62 1663 1664 O
estrogen 62 70 1664 1672 B-treatment
, 70 71 1672 1673 O
progesterone 72 84 1674 1686 B-treatment
, 84 85 1686 1687 O
and/or 86 92 1688 1694 O
testosterone 93 105 1695 1707 B-treatment
preparations 106 118 1708 1720 O
) 118 119 1720 1721 O

Women 0 5 1722 1727 B-gender

men 0 3 1728 1731 B-gender
of 4 6 1732 1734 O
childbearing 7 19 1735 1747 O
potential 20 29 1748 1757 O
unwilling 30 39 1758 1767 B-contraception_consent
to 40 42 1768 1770 I-contraception_consent
take 43 47 1771 1775 I-contraception_consent
adequate 48 56 1776 1784 I-contraception_consent
precautions 57 68 1785 1796 I-contraception_consent
to 69 71 1797 1799 O
avoid 72 77 1800 1805 O
pregnancy 78 87 1806 1815 B-pregnancy
from 88 92 1816 1820 O
the 93 96 1821 1824 O
start 97 102 1825 1830 O
of 103 105 1831 1833 O
protocol 106 114 1834 1842 B-treatment
treatment 115 124 1843 1852 I-treatment
through 125 132 1853 1860 O
28 133 135 1861 1863 B-upper_bound
days 136 140 1864 1868 I-upper_bound
after 141 146 1869 1874 I-upper_bound
the 147 150 1875 1878 O
last 151 155 1879 1883 B-treatment
treatment 156 165 1884 1893 I-treatment

